Added to YB: 2023-05-14
Pitch date: 2023-05-14
MACK [bullish]
Merrimack Pharmaceuticals, Inc.
+21.62%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company in the United States. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
Market Cap
$223.7M
Pitch Price
$0.02
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-161.29
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
MERRIMACK PHARMACEUTICALS MACK
A summary for this pitch has not been created yet.
Read full article (0 min)